Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction

Microbiology and Immunology

Volumn 48, Issue 7, 2004, Pages 507-517

  Takao, Yukari ^a,b   Yamada, Akira ^b   Yutani, Shigeru ^a   Sata, Michio ^a   Itoh, Kyogo ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

Antibody; Cytotoxic T lymphocytes; HCV; Peptide

Indexed keywords

ANTIBODY; CORE PROTEIN; EPITOPE; HEPATITIS C ANTIBODY; HLA A2 ANTIGEN; IMMUNOGLOBULIN G; PEPTIDE;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 3242763171     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03546.x     Document Type: Article

References (25)

1. Alexander, J., Del Guercio, M.F., Fikes, J.D., Chesnut, R.W., Chisari, F.V., Chang, K.M., Appella, E., and Sette, A. 1998. Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity. Hum. Immunol. 59: 776-782.
2. Akatsuka, T., Donets M., Scaglione, L., Ching, W.M., Shih, J. W.-K., Di Bisceglie, A.M., and Feintone, S.M. 1993. B cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies. Hepatology 18: 503-510.
3. Battegay, M., Fikes, J., Di Bisceglie, A.M., Wentworth, P.A., Sette, A., Celis, E., Ching, W.M., Grakoui, A., Rice, C.M., Kurokohchi, K., Berzofsky, J.A., Hoofnagle J.H., Feinstone, S.M., and Akatsuka, T. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69: 2462-2470.
4. Cai, Q., Zhang, X., Tian, L., Yuan, M., Jin, G., and Lu, Z. 2002. Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China. J. Med. Virol. 67: 490-500.
5. Cerino, A., Boender, P., Lamonica, N., Rosa, C., Habets, W., and Mondelli, M.U. 1993. A human monoclonal antibody specific for the N-terminus of the hepatitis-C virus nucleocapsid protein. J. Immunol. 151: 7005-7015.
6. Cerny, A., McHutchison, J.G., Pasquinelli, C., Brown, M.E., Brothers, M.A., Grabsheid, B., Flower, P., Houghton, M., and Chisari, F.V. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95: 521-530.
7. Chander, G., Sulkowski, M.S., Jenckes, M.W., Torbenson, M.S., Herlong, H.F., Bass, E., and Gebo, K.A. 2002. Treatment of chronic hepatitis C: a systematic review. Hepatology 36 (Suppl): S135.
8. El Awady, M.K., El-Demellawy, M.A., Khalil, S.B., Galal, D., and Goueli, S.A. 2002. Synthetic peptide-based immunoassay as a supplemental test for HCV infection. Clin. Chim. Acta 325: 39-46.
9. Encke, J., Zu, Putlitz, J., Geissler, M., and Wands, J.R. 1998. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J. Immunol. 161: 4917-4923.
10. Harada, M., Kobayashi, K., Matsueda, S., Nakagawa, M., Noguchi, M., and Itoh, K. 2003. Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral response in HLA-A24+ prostate cancer patients. Prostate 57: 152-159.
11. Hida, N., Maeda, Y., Katagiri, K., Takasu, H., Harada, M., and Itoh, K. 2002. A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation. Cancer Immunol. Immunother. 51: 219-228.
12. Hunziker, I.P., Zurbriggen, R., Glueck, R., Engler, O.B., Reichen, J., Dai, W.J., Pichler, W.J., and Cerny, A. 2001. Perspectives: towards a peptide-based vaccine against hepatitis C virus. Mol. Immunol. 38: 475-484.
13. Ito, M., Shichijo, S., Tsuda, N., Ochi M., Harashima, N., Saito, N., and Itoh, K. 2001. Molecular basis of T cell-mediated recognition of pancreatic cancer cells. Cancer Res. 61: 2038-2046.
14. Kawamoto, N., Yamada, A., Ohkouchi, S., Maeda, T., Tanaka, S., Hashimoto, T., Saijio, Y., Saijio, S., Nukiwa, T., Shichijio, S., Aizawa, H., and Itoh, K. 2003. IgG reactive to CTL-directed epitopes of self-antigens is either lacking or unbalanced in atopic dermatitis patients. Tissue Antigens 61: 1-10.
15. Kurokohchi, K., Arima, K., and Nishioka, M. 2001. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection. J. Hepatol. 34: 930-935.
16. Mine, T., Gouhara, R., Hida, N., Imai, N., Azuma, K., Rikimaru, T., Katagiri, K., Nishikori, M., Sukehiro, A., Nakagawa, M., Yamada, A., Aizawa, H., Shirouzu, K., Itoh, K., and Yamana, H. 2003. Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients. Cancer Sci. 94: 548-556.
17. Noguchi, M., Kobayashi, K., Suetsugu, N., Tomiyasu, K., Suekane, S., Yamada, A., Itoh, K., and Noda, S. 2003. Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination. Prostate 1: 80-92.
18. Ohkouchi, S., Yamada, A., Imai, N., Mine, T., Harada, K., Shichijio, S., Maeda, Y., Saijio, Y., Nukiwa, T., and Itoh, K. 2002. Non-mutated tumor-rejection antigen peptides elicit type-I allergy in the majority of healthy individuals. Tissue Antigens 59: 259-272.
19. Pumeechockchai, W., Bevitt, D., Agarwal, K., Petropoulou, T., Langer, B.C., Belohradsky, B., Bassendine, M.F., and Toms, G.L. 2002. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: implications for virus clearance by antibody. J. Med. Virol. 68: 335-342.
20. Rammensee, H.G., Friede, T., and Stevanoviic, S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
21. Sato, Y., Shomura, H., Maeda, Y., Mine, T., Une, Y., Akasaka, Y., Kondo, M., Takahashi, S., Shinohara, T., Katagiri, K., Sato, M., Okada, S., Matsui, K., Yamada, A., Itoh, K., and Todo, S. 2003. Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide. Cancer Sci. 9: 802-808.
22. Tanaka, T., Lau, J.Y., Mizokami, M., Orito, E., Tanaka, E., Kiyosawa, K., Yasui, K., Ohta, Y., Hasegawa, A., Tanaka, S., et al. 1995. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J. Hepatol. 23: 742-745.
23. Urbani, S., Uggeri, J., Matsuura, Y., Miyamura, T., Penna, A., Boni, C., and Ferrari, C. 2001. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology 33: 1533-1543.
24. Vertuani, S., Bazzaro, M., Gualandi, G., Micheletti, F., Marastoni, M., Fortini, C., Canella, A., Marino, M., Tomatis, R., Traniello, S., and Gavioli, R. 2002. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals. Eur. J. Immunol. 32: 144-154.
25. Ward, S., Lauer, G., Isba, R., Walker, B., and Klenerman, P. 2002. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin. Exp. Immunol. 128: 195-203.